Parkinson Fran, Ferguson Stuart, Lewis Peter, Williams Ian M, Twine Christopher P
Department of Vascular Surgery, Royal Gwent Hospital, Newport, United Kingdom.
Department of Vascular Surgery, University Hospital of Wales, Cardiff, United Kingdom.
J Vasc Surg. 2015 Jun;61(6):1606-12. doi: 10.1016/j.jvs.2014.10.023. Epub 2015 Feb 7.
Elective abdominal aortic aneurysm (AAA) surgery relies on balancing the risk of the intervention against the risk of the aneurysm causing death. Although much is known about intervention at 5.5 cm, little is known about the fate of the patient unfit for elective surgery at this threshold. Medical therapy and endovascular surgery have revolutionized management of aortic aneurysms in the last 20 years and are thought to have affected rupture rates.
MEDLINE via PubMed, EMBASE, and the Cochrane Library Database were searched for studies reporting follow-up of untreated large AAA approach from inception to January 2014. Data were pooled using random-effects analysis with standardized mean differences and 95% confidence intervals (CIs) reported. The primary end points were rupture rates and all-cause mortality per year by AAA size.
The search strategy identified 1892 citations, of which 11 studies comprising 1514 patients experiencing 347 ruptured AAA were included. The overall incidence of ruptured AAA in patients with AAA >5.5 cm was 5.3% (95% CI, 3.1%-7.5%) per year. This represented cumulative yearly rupture rates of 3.5% (95% CI, -1.6% to 8.7%) in AAAs 5.5 to 6.0 cm, 4.1% (95% CI, -0.7% to 9.0%) in AAAs 6.1 to 7.0 cm, and 6.3% (95% CI, -1.8% to 14.3%) in AAAs >7.0 cm. There was no heterogeneity between studies (I(2) = 0%). Only 32% of these patients were offered repair on rupturing an AAA, with a perioperative mortality of 58% (95% CI, 32%-83%). The risk of death from causes other than AAA was higher than the risk of death from rupture.
Rupture rates of untreated AAA were lower than those currently quoted in the literature. Non-AAA-related mortality in this group of patients is high.
择期腹主动脉瘤(AAA)手术依赖于平衡干预风险与动脉瘤导致死亡的风险。尽管对于直径5.5厘米时的干预措施已有很多了解,但对于在此阈值下不适合择期手术的患者的预后却知之甚少。在过去20年中,药物治疗和血管内手术彻底改变了主动脉瘤的治疗方式,并被认为影响了破裂率。
通过PubMed检索MEDLINE、EMBASE和Cochrane图书馆数据库,查找报告未经治疗的大型AAA从开始到2014年1月随访情况的研究。使用随机效应分析合并数据,并报告标准化均数差值和95%置信区间(CI)。主要终点是按AAA大小计算的每年破裂率和全因死亡率。
检索策略共识别出1892条引文,其中包括11项研究,共1514例患者,发生347例AAA破裂。AAA直径>5.5厘米患者中AAA破裂的总体发生率为每年5.3%(95%CI,3.1%-7.5%)。这代表直径5.5至6.0厘米的AAA每年累积破裂率为3.5%(95%CI,-1.6%至8.7%),直径6.1至7.0厘米的AAA为4.1%(95%CI,-0.7%至9.0%),直径>7.0厘米的AAA为6.3%(95%CI,-1.8%至14.3%)。各研究间无异质性(I² = 0%)。这些患者中只有32%在AAA破裂时接受了修复,围手术期死亡率为58%(95%CI,32%-83%)。非AAA相关原因导致的死亡风险高于破裂导致的死亡风险。
未经治疗的AAA破裂率低于目前文献中引用的破裂率。该组患者中非AAA相关死亡率很高。